Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Overactive bladder (OAB) is a syndrome characterized by symptoms of a sudden need to urinate
with or without incontinence (leaking). The purpose of this study is to test whether
dexmecamylamine is safe and effective compared to placebo for the treatment of symptoms of
OAB.